相关实验视频
Updated: Jun 5, 2025

03:25
Simple Continuous Glucose Monitoring in Freely Moving Mice
Published on: February 24, 2023
5.2K
[持续血糖监测的进步:新一代技术的证据]
León Litwak1, Matías Ré2, Adrián Proietti3
1Servicio de Endocrinología, Metabolismo y Medicina Nuclear, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Medicina
|December 12, 2024
概括
自由式自由2 (FSL2) 连续血糖监测系统为糖尿病管理提供准确的实时血糖读数. 这种系统可以改善糖尿病患者的射程时间和生活质量.
科学领域:
- 内分泌学 在内分泌学.
- 医疗器械 医疗器械
- 糖尿病管理 糖尿病管理
背景情况:
- 持续血糖监测 (CGM) 为糖尿病管理提供了动态见解.
- 自由式自由 2 (FSL2) 是一个集成的CGM系统,具有实时读数和可定制的警报.
- 进行了全球文献审查,以评估FSL2的证据和影响.
研究的目的:
- 总结使用FreeStyle Libre 2 (FSL2) CGM系统在DM患者中的证据和临床影响.
- 评估FSL2对血糖控制和生活质量的准确性和影响.
主要方法:
- 一个全面的全球文献综述,涵盖所有与DM患者FSL2使用相关的研究类型.
- 证据的定性陈述与专家临床意见相结合.
- 分析涉及2岁及以上1型DM (DM1) 或2型DM (DM2) 的参与者的研究.
主要成果:
- FSL2表现出高临床准确性,总体平均绝对相对差异为8.2%.
- 在DM1中,FSL2的使用导致范围内的时间增加和范围以下和范围以上的时间减少,与血液监测相比.
- 关于DM的观察性研究证实了这些发现,大多数使用者报告治疗满意度提高和生活质量改善.
结论:
- 该FSL2系统提供准确的,实时的葡萄糖监测,以有效管理糖尿病.
- 结合FSL2可以降低DM并发症风险,改善患者的预后,并优化医疗保健资源利用率.
- 对于糖尿病患者来说,FSL2在血糖控制,患者满意度和整体生活质量方面具有显著的好处.
相关概念视频
Pulse rhythm
763
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
763
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Hypoglycemia and Glucagon
152
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
152
Amperometry: Overview
446
Amperometry is a technique commonly used to measure the concentration of specific analytes in a solution by monitoring the electric current generated during an electrochemical reaction. It involves applying a constant potential between a working electrode and a reference electrode to measure the resulting current, which is proportional to the concentration of the analyte. The Clark oxygen electrode operates based on this principle of amperometry. It consists of a cathode and an anode enclosed...
446
Glucose Absorption Into the Small Intestine
31.3K
Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...
31.3K
Glucagon-like Receptor Agonists
298
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
298

